149 related articles for article (PubMed ID: 33727198)
21. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant treatment of cancer I. Large bowel cancer.
Nystrom JS; Viola MV
Conn Med; 1977 May; 41(5):265-70. PubMed ID: 862395
[No Abstract] [Full Text] [Related]
23. Immunotherapy of cancer in man. VII. Studies of patients with cancer of the alimentary tract.
Humphrey LJ; Murray DR; Boehm OR; Jewell WR; Griffen WO
Am J Surg; 1971 Feb; 121(2):165-8. PubMed ID: 4322276
[No Abstract] [Full Text] [Related]
24. Active immunotherapy against cancer: present status.
Morton DL
Semin Oncol; 1986 Jun; 13(2):180-5. PubMed ID: 3520826
[No Abstract] [Full Text] [Related]
25. [Clinical factors of pathological complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Sha YJ; Wu HT; Wen XY; Wang CB
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):859-863. PubMed ID: 32234159
[No Abstract] [Full Text] [Related]
26. Results of postoperative treatment of colorectal cancer by radiotherapy, chemotherapy and immunotherapy.
Robinson E; Bartal A; Mekori T
Recent Results Cancer Res; 1980; 75():80-7. PubMed ID: 7232842
[TBL] [Abstract][Full Text] [Related]
27. Current adjuvant trials in colorectal cancer.
Kisner DL; Davis HL; Muggia FM
Front Gastrointest Res; 1979; 5():102-15. PubMed ID: 387559
[No Abstract] [Full Text] [Related]
28. Immunotherapy of cancer: current status.
Goodnight JE; Morton DL
Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
[No Abstract] [Full Text] [Related]
29. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.
de Rosa N; Rodriguez-Bigas MA; Chang GJ; Veerapong J; Borras E; Krishnan S; Bednarski B; Messick CA; Skibber JM; Feig BW; Lynch PM; Vilar E; You YN
J Clin Oncol; 2016 Sep; 34(25):3039-46. PubMed ID: 27432916
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors associated with complete pathological response after neoadjuvant treatment for rectal cancer.
Hajer J; Rim A; Ghorbel A; Amani Y; Ines L; Asma B; Chiraz N
Cancer Radiother; 2021 May; 25(3):259-267. PubMed ID: 33422417
[TBL] [Abstract][Full Text] [Related]
31. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.
Smith FM; Wiland H; Mace A; Pai RK; Kalady MF
Dis Colon Rectum; 2014 Mar; 57(3):311-5. PubMed ID: 24509452
[TBL] [Abstract][Full Text] [Related]
32. Treatment of colon and rectal cancer.
Blumberg D; Ramanathan RK
J Clin Gastroenterol; 2002 Jan; 34(1):15-26. PubMed ID: 11743241
[TBL] [Abstract][Full Text] [Related]
33. Active immunotherapy in colorectal cancer.
Hoover HC; Hanna MG
Semin Surg Oncol; 1989; 5(6):436-40. PubMed ID: 2688033
[TBL] [Abstract][Full Text] [Related]
34. [Two Cases of Pathological Complete Response with Neoadjuvant Therapy for Advanced Rectal Cancer].
Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Motoori M; Nakatsuka R; Okumura Y; Nomura M; Nishimura M; Kitagawa A; Matsuura N; Fushimi H; Iwase K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2313-5. PubMed ID: 26805348
[TBL] [Abstract][Full Text] [Related]
35. [Rectal cancers: an update].
Atlan D; Fabre E; Maingon P; Penna C; Rougier P
Bull Cancer; 2000 Sep; Suppl 4():21-32. PubMed ID: 11072222
[No Abstract] [Full Text] [Related]
36. Radiotherapy and rectal cancer.
Kligerman MM
Cancer; 1977 Feb; 39(2 Suppl):896-900. PubMed ID: 65209
[TBL] [Abstract][Full Text] [Related]
37. [A Case of Locally Advanced Rectal Cancer with a Pathological Complete Response to Preoperative Chemoradiotherapy].
Akahoshi S; Iizaka M; Murakami S; Nimura S; Takeguchi T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2316-8. PubMed ID: 26805349
[TBL] [Abstract][Full Text] [Related]
38. The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy.
Domenick NP
Nurs Clin North Am; 1978 Jun; 13(2):369-80. PubMed ID: 353752
[No Abstract] [Full Text] [Related]
39. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
[TBL] [Abstract][Full Text] [Related]
40. Management of adenomas within the area of rectal cancer that develop complete pathological response.
Habr-Gama A; Vianna MR; São Julião GP; Rawet V; Gama-Rodrigues J; Proscurshim I; Alves J; Fernandez LM; Perez RO
Int J Colorectal Dis; 2015 Sep; 30(9):1285-7. PubMed ID: 26243467
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
